Skip to search.
 TSX Up 0.47% TSX Ventures Up 0.38%

BioMarin Pharmaceutical Inc. (BMRN)

-NasdaqGS
129.26 Up 4.63(3.71%) Sep 2, 4:00PM EDT
Add to Portfolio
Prev Close:124.63
Open:126.43
Bid:126.78 x 100
Ask:134.99 x 1200
1y Target Est:159.67
Beta:1.09673
Earnings Date:Oct 21 - Oct 26 (Est.)
Day's Range:124.43 - 129.39
52wk Range:65.91 - 151.75
Volume:1,079,639
Avg Vol (3m):1,299,520
Market Cap:20.82B
P/E (ttm):N/A
EPS (ttm):-1.38
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
BMRNUp 3.71%20.82B
FOLDUp 4.41%1.77B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):23.31
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-2.20
Quarterly EPS Est (Sep-15) :-0.64
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):-2.35

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BioMarin Pharmaceutical Inc. develops and commercializes pharmaceuticals for serious diseases and medical conditions in the United States, Europe, Latin America, and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback